Clinical Trial Update: A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated cisplatin and pemetrexed with radiotherapy for small cell lung cancer; the trial was terminated and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Small Cell Lung Cancer, Carcinoma, Small Cell | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2009-08-26